Clinical Trial Update: A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating pegloticase administration by subcutaneous vs intravenous routes, both with methotrexate, in people with uncontrolled gout…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Pegloticase (pegloticase)

Snippet

Sponsor: Amgen | Conditions: Uncontrolled Gout | Phase 3 | Status: RECRUITING